| Cardiac Science Corporation and Cambridge Heart, a developer of noninvasive diagnostic tests for cardiac disease, announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23. Under the agreement, the companies are collaborating to develop a Microvolt T-Wave Alternans module, which will be integrated with Cardiac Science’s cardiac stress test systems. Cambridge Heart has completed the prototype development of the module, which is now subject to industry standard validation and verification processes, and regulatory approval. :theflyonthewall.com |
